Agreement facilitating the accelerated fulfillment for hundreds more specialty medications across one of healthcare’s largest provider networks
CHICAGO, May 12, 2020 — Allscripts (NASDAQ: MDRX) business unit Veradigm® a leading provider of data and technology solutions, today announced the signing of an agreement with Surescripts to enhance its Veradigm AccelRx™ specialty medication fulfillment solution with Surescripts Specialty Patient Enrollment. The agreement will enable AccelRx to support healthcare providers in more quickly fulfilling prescriptions for hundreds more types of specialty medications by incorporating Surescripts’ expansive health information network, further streamlining healthcare providers’ management of specialty medication within their electronic health record workflow.
Representing less than 3% of all prescriptions written in the U.S. in 2020, specialty medications are expected to account for up to 50% of the total drug spend.1 To receive their specialty medication, a patient’s prescription must pass through a broad cross-section of healthcare stakeholders, from biopharma companies and payers, to specialty pharmacies and specialty medication hubs. Each of these entities may have their own, standalone online portal for facilitating fulfilment for a single drug or manufacturer. With so many manufacturers and payers directly involved in the delivery of specialty medications, it can be easy for providers and even specialty medication hubs to be overwhelmed.
The result is often that instead of taking days to receive their specialty medication, it takes weeks or even months. Despite this rapid growth, recent data from Veradigm has shown that specialty drugs are 50% less likely to be electronically prescribed.2
Combining one of healthcare’s largest prescriber bases with broad industry partnerships built over decades of e-prescribing and prior authorization leadership, Veradigm AccelRx delivers a unique software platform designed to streamline specialty medication fulfillment.
“Veradigm is excited to join with Surescripts in strengthening the ability of Allscripts’ network of healthcare providers to reduce or eliminate the many phone calls and faxes associated with enrolling patients for specialty medication prescriptions,” says Tom Langan, Veradigm CEO. “In our unique position at the nexus of point-of-care patient solutions and clinical data insight, our many biopharma and payer partners are looking to us for support in streamlining this process. With this agreement, Veradigm AccelRx will be enabled to deliver a solution for hundreds of specialty medications and help us rapidly progress toward our goal of covering every specialty medication for every therapeutic area.”
By enabling providers to enroll patients into specialty programs in the EHR and coordinating information sent to the pharmacy, while the patient is still in their office, Veradigm AccelRx, in collaboration with partners like Surescripts, delivers the tools providers need to overcome the existing gaps and speed up the specialty medication fulfillment process.
“When we replace manual work with an accurate, electronic workflow, patients get essential therapies sooner and providers have more time to do what matters most, help patients,” said Mike Pritts, Surescripts Chief Product Officer. “Together with Veradigm, we can help drive meaningful change for all providers using AccelRx to accelerate and simplify specialty medication enrollment to the pharmacy and specialty medication hub.”
Learn more about the Veradigm AccelRx solution here.
Veradigm is an integrated data systems and services company that combines data-driven clinical insights with actionable tools to help healthcare stakeholders improve the quality, efficiency, and value of healthcare delivery— including biopharma, health plans, healthcare providers, health technology partners, and most importantly, the patients they serve. We are dedicated to simplifying the complicated healthcare system with next-generation healthcare solutions. This is how we are transforming health, insightfully. To learn more, visit www.veradigm.com.
Veradigm® is a business unit of Allscripts.
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
1 Pharmaceutical Executive. 2015 Pharm Sci-ence Strategic Outlook. 2015.
2 Data on file. 2019.